The technical term for this completion is CLOSE OUT. It will release the last part of the award, 15+%, about $100K but more importantly now opens up the potentially more lucrative/profitable SBIR Phase III. Of course the company should be telling you all this, not me.
Too bad this company is not doing much in terms of selling its mass spec, or developing the hand held mass spec (and if they are, we aren't hearing about it). The market is clearly there, on a day where we have blasts in Boston. Mass spec technology could have gone a long way to perhaps help stop attacks like this one.